Marcin Okroj (Former)
1 – 50 of 50
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism
(
- Contribution to journal › Article
- 2020
-
Mark
Calcein release assay as a method for monitoring serum complement activity during monoclonal antibody therapy in patients with B-cell malignancies
(
- Contribution to journal › Article
-
Mark
Gain-of-function mutation in complement C2 protein identified in a patient with aHUS
(
- Contribution to journal › Letter
-
Mark
Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
(
- Contribution to journal › Article
- 2019
-
Mark
Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics
(
- Contribution to journal › Article
-
Mark
Measuring plasma C4D to monitor immune complexes in lupus nephritis
(
- Contribution to journal › Article
- 2018
-
Mark
Overactivity of alternative pathway convertases in patients with complement-mediated renal diseases
(
- Contribution to journal › Article
-
Mark
Genetic predisposition to infection in a case of atypical hemolytic uremic syndrome
(
- Contribution to journal › Article
-
Mark
Complement C4d-specific antibodies for the diagnosis of lung cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Factor I
2017) p.147-154(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
C4b-Binding Protein
2017) p.251-259(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2016
-
Mark
The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis
(
- Contribution to journal › Article
-
Mark
New perspectives on complement mediated immunotherapy
(
- Contribution to journal › Scientific review
-
Mark
Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
(
- Contribution to journal › Article
-
Mark
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
(
- Contribution to journal › Article
-
Mark
Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Antibodies reactive to cleaved sites in complement proteins enable highly specific measurement of soluble markers of complement activation.
(
- Contribution to journal › Article
-
Mark
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.
(
- Contribution to journal › Article
- 2014
-
Mark
Distinct inflammatory mediator patterns characterize infectious and sterile systemic inflammation in febrile neutropenic hematology patients.
(
- Contribution to journal › Article
-
Mark
A novel method for direct measurement of complement convertases activity in human serum.
(
- Contribution to journal › Article
- 2013
-
Mark
Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase.
(
- Contribution to journal › Article
-
Mark
Killing of CLL and NHL cells by rituximab and ofatumumab under limited availability of complement.
(
- Contribution to journal › Article
-
Mark
Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies.
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Functional analyses of complement convertases using c3 and c5-depleted sera.
(
- Contribution to journal › Article
-
Mark
Heavy chains of inter alpha inhibitor (IαI) inhibit the human complement system at early stages of the cascade .
(
- Contribution to journal › Article
- 2011
-
Mark
Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.
(
- Contribution to journal › Article
- 2010
-
Mark
Inter alpha inhibitor (IaI) as novel inhibitor of human complement system
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Inter alpha inhibitor (I alpha I) inhibits classical complement pathway at C1 level
2009) 12th European Meeting on Complement in Human Disease In Molecular Immunology 46(14). p.2860-2860(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of the complement inhibitory function of Rhesus rhadinovirus complement control protein (RCP).
(
- Contribution to journal › Article
-
Mark
Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack.
(
- Contribution to journal › Article
- 2008
-
Mark
Characterization of the complement inhibitory function of Rhesus rhadinovirus
(
- Contribution to journal › Published meeting abstract
-
Mark
Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors
(
- Contribution to journal › Article
-
Mark
C4BP binds also to dead cells outside the blood compartment
(
- Contribution to journal › Published meeting abstract
-
Mark
C4b-binding protein is present in affected areas of myocardial infarction during the acute inflammatory phase and covers a larger area than C3.
(
- Contribution to journal › Article
-
Mark
Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalis.
(
- Contribution to journal › Article
-
Mark
Structural basis and functional effects of the interaction between complement inhibitor C4b-binding protein and DNA.
(
- Contribution to journal › Article
- 2007
-
Mark
Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals
(
- Contribution to journal › Article
-
Mark
Molecular characterization of the rhesus rhadinovirus (RRV) ORF4 gene and the RRV complement control protein it encodes
(
- Contribution to journal › Article
-
Mark
In Vitro Activity of Lipopeptides Pal-Lys-Lys-NH2 and Pal-Lys-Lys Alone and in Combination with Antimicrobial Agents against Multiresistant Gram-positive Cocci.
(
- Contribution to journal › Article
-
Mark
Rheumatoid arthritis and the complement system
(
- Contribution to journal › Article
- 2006
-
Mark
Temporin A and its retro-analogues: synthesis, conformational analysis and antimicrobial activities
(
- Contribution to journal › Article
-
Mark
Ischemia induces nuclear NOX2 expression in cardiomyocytes and subsequently activates apoptosis
(
- Contribution to journal › Article
-
Mark
In vitro activity of synthetic antimicrobial peptides against Candida
(
- Contribution to journal › Article
-
Mark
The atypical pattern of cell death in B16F10 melanoma cells treated with TNP-470
(
- Contribution to journal › Article
- 2005
-
Mark
A novel mechanism of action of the fumagillin analog, TNP-470, in the B16F10 murine melanoma cell line
(
- Contribution to journal › Article
- 2003
-
Mark
In vitro and in vivo analyses of the biological activity of RGD peptides towards Ab Bomirski melanoma
(
- Contribution to journal › Article
-
Mark
Novel properties of antimicrobial peptides
(
- Contribution to journal › Scientific review